CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties

Mayer LD, Tardi P, Louie AC

International Journal of Nanomedicine 2019, 14:3819-3830

Published Date: 23 May 2019